Trial averages: 20.2% on tirzepatide and 13.7% on semaglutide at 72 weeks (SURMOUNT-5)
Associated with right upper quadrant abdominal pain , especially if accompanied by jaundice, dark urine, or pale stoolsthese symptoms may suggest gallbladder disease (cholecystitis or cholelithiasis), which occurs at increased rates with GLP-1 therapy
One of the innovative treatments we provide is Semaglutide GLP-1, a proven medication for effective weight management
If you are taking semaglutide for Type 2 diabetes or another metabolic condition and also have a compromised immune system, are post-surgical, receiving cancer treatment, or have a serious GI condition such as Crohn's disease or short bowel syndrome, discuss probiotic use with your prescribing clinician before starting
These combined effects deteriorate the overall quality of life and necessitate comprehensive treatment and support
Cell 111 YohK.ItohK.EnomotoA.HirayamaA.YamaguchiN.KobayashiM.et al (2001)